Risks of Impaired Organ Protection with Inhibiting Transient Receptor Potential Vanilloid 1
- PMID: 30020180
- PMCID: PMC6430147
- DOI: 10.1097/ALN.0000000000002293
Risks of Impaired Organ Protection with Inhibiting Transient Receptor Potential Vanilloid 1
Conflict of interest statement
ERG holds a US patent titled “
Comment in
-
In Reply.Anesthesiology. 2018 Aug;129(2):378-379. doi: 10.1097/ALN.0000000000002294. Anesthesiology. 2018. PMID: 30020181 No abstract available.
Comment on
-
Transient Receptor Potential Vanilloid 1 Antagonists Prevent Anesthesia-induced Hypothermia and Decrease Postincisional Opioid Dose Requirements in Rodents.Anesthesiology. 2017 Nov;127(5):813-823. doi: 10.1097/ALN.0000000000001812. Anesthesiology. 2017. PMID: 28806222
References
-
- Garami A, Ibrahim M, Gilbraith K, Khanna R, Pakai E, Miko A, Pinter E, Romanovsky AA, Porreca F, Patwardhan AM. Transient Receptor Potential Vanilloid 1 Antagonists Prevent Anesthesia-induced Hypothermia and Decrease Postincisional Opioid Dose Requirements in Rodents. Anesthesiology. 2017;127:813–823. - PubMed
-
- Wang L, Wang DH. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation. 2005;112:3617–23. - PubMed
-
- Wang M, Ji P, Wang R, Zhao L, Xia Z. TRPV1 agonist capsaicin attenuates lung ischemia-reperfusion injury in rabbits. J Surg Res. 2012;173:153–60. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
